STAT+'s June 11, 2026 update on RFK Jr.'s HHS promises shows a ledger weighted toward in progress and unfulfilled commitments, anchored by a missed September 2025 deadline to name an autism "root cause."
One year into Robert F. Kennedy Jr.'s tenure as Health and Human Services Secretary, the most concrete pledge on his Make America Healthy Again agenda has slipped past its deadline. Kennedy promised that HHS would identify a "root cause" of autism "by September" 2025. The deadline came and went. As of the June 11, 2026 update of STAT+'s accountability tracker, the administration has not named that cause.
STAT+ organizes Kennedy's MAHA promises into three buckets: met, in progress or reshaped, and unfulfilled. The latest version, by chronic disease reporter Isabella Cueto and STAT data editor J. Emory Parker, is framed as a working document rather than a verdict, and the framing matters. A tracker only earns its keep if it tracks movement, and the autism pledge is the cleanest test of whether the department can convert campaign language into a public, falsifiable deliverable.
Kennedy has insisted the record tells a different story. He has publicly claimed, via X, an "unprecedented list of accomplishments on a wide range of issues, all of which I drove." That framing is not unreasonable on its face. The MAHA agenda spans food dyes, pesticide reviews, vaccine policy, and a chronic-disease push that touches nearly every operating decision at HHS. A year is also a short clock for an agency that large. The audit only becomes unfair if the tracker is treated as a personality test rather than a tool. The ledger simply lays out, by row, what was promised and where each commitment currently stands.
The categories that have stalled carry the most weight for operators in food, pharma, and public health. The chronic-disease agency Kennedy pitched as a center of gravity for the MAHA mission has not been funded. Direct-to-consumer drug advertising, a long-standing Republican target that Kennedy endorsed on the campaign trail, remains legal. The food-additive removals and pesticide reviews the White House has promoted in briefings have produced rulemaking, but most of those actions are pending or under litigation. Each row in the ledger has a different reason for its current status, and the tracker's value is that it forces a sharper question: which stalls are policy, which are process, and which are legal exposure the administration has chosen not to absorb.
A wire summary of the tracker would list each promise and its status. The second-order read is that the categories themselves have become a story. Kennedy's framing implies a stack of completed wins. The bucket distribution, weighted toward in-progress and unfulfilled, has not been publicly owned by the department in those terms, which is itself a data point for anyone planning around an unpredictable HHS. Operators do not need a personality verdict to make a calendar. They need to know which promises are stuck, which are moving, and on what clock.
The ledger will move. The most consequential update to watch is whether the autism file produces a named cause, a refocused research agenda, or a quiet retreat from the September 2025 commitment. The food-additive and pesticide tracks have clearer regulatory paths and faster clocks. The chronic-disease agency, by contrast, is a budget question as much as a policy one, and that puts it on a different timeline entirely. The tracker's value is that it makes those clocks visible, one row at a time, and gives readers a framework they can return to as the record updates.